A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial

Autor: de Winter, Robbert J, Katagiri, Yuki, Asano, Taku, Milewski, Krzysztof P, Lurz, Philipp, Buszman, Pawel, Jessurun, Gillian A J, Koch, Karel T, Troquay, Roland P T, Hamer, Bas J B, Ophuis, Ton Oude, Wöhrle, Jochen, Wyderka, Rafał, Cayla, Guillaume, Hofma, Sjoerd H, Levesque, Sébastien, Żurakowski, Aleksander, Fischer, Dieter, Kośmider, Maciej, Goube, Pascal, Arkenbout, E Karin, Noutsias, Michel, Ferrari, Markus W, Onuma, Yoshinobu, Wijns, William, Serruys, Patrick W
Zdroj: In The Lancet 3-9 February 2018 391(10119):431-440
Databáze: ScienceDirect